fr   en
Agreements
Select a partner :
Type of agreement :





Select a compound/Disease :
Choose date:
[<<]      «      52   |   53   |   54   |   55   |   56   |   57   |   58   |   59   |   60   |   61   |   62      »      [65]
Date Partners Compound / Disease area / Development phase Type of agreement Nature / Financial terms
2007-04-02 ProFibrix (The Netherlands)/Bioceros (The Netherlands)
 
  /   R&D
See details
2007-04-02 Atlantic Healthcare (UK)
Isis Pharmaceuticals (USA)
alicaforsen (ICAM-1 antisense compound) and its successors / inflammatory diseases including Crohn's disease, ulcerative colitis and pouchitis licensing
See details
2007-03-30 Vivalis (France)
Bavarian Nordic (Denmark)
EBx® cell line as a production platform for MVA-BN® based vaccines licensing
See details
2007-03-30 Cerep (France)
Pfizer (USA)
The BioPrint® database /   licensing
See details
2007-03-29 Pevion Biotech (Switzerland)/Mymetics (Switzerland/USA)
 
vaccine / AIDS licensing
See details
2007-03-28 Affitech (Norway)/Micromet (Germany)
 
the SCA technology (single-chain antibodies) /   R&D
licensing
See details
2007-03-28 Oxford Biomedica (GB)
Sanofi-Aventis (France)
TroVax® (immunotherapy) / kidney cancer licensing
See details
2007-03-28 Morphosys (Germany)
Astellas Pharma (Japan)
Morphosys' Hucal® antibody library. /   licensing
See details
2007-03-26 Crucell/DSM Biologics (The Netherlands)/ Development Center for Biotechnology (DCB) (Taiwan)
 
PER.C6® technology /   licensing
See details
2007-03-22 Novagali Pharma (France)
Topigen Pharmaceuticals (Canada)
 
Platform Novasorb®/TPI ASM8 / eye allergies other
See details
2007-03-22 MilleGen (France)
LFB (France)
recombinant monoclonal antibodies other
See details
2007-03-22 Crucell (The Netherlands)/ADImmune (Taiwan)
 
  / virosomal vaccine against influenza licensing
See details
2007-03-16 Micromet (Germany/USA)
Tracon Pharmaceuticals (USA)
D93/TRC093 (first-in-class humanized monoclonal antibody that binds to cleaved collagen to inhibit angiogenesis and tumor growth) / cancer licensing
commercialization/ distribution
development
See details
2007-03-12 Lonza (Switzerland)
BMS (USA)
Orencia® (abatcept) / rheumatoid arthritis other
See details
2007-03-08 BioAlliance Pharma (France)/Spepharm (The Netherlands)
 
Loramyc® /   other
See details
[<<]      «      52   |   53   |   54   |   55   |   56   |   57   |   58   |   59   |   60   |   61   |   62      »      [65]